Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Optometry
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2024 / Dec / DNA Damage
Research & Innovations Retina

DNA Damage

Retinal DNA damage linked to development of age-related macular degeneration (AMD) in new Aging Cell study

By The Ophthalmologist 12/18/2024 1 min read

Share

Researchers have uncovered significant insights into retinal aging through inspecting the neural retina and retinal pigment epithelium (RPE) of Ercc1−/Δ mice, a mouse model which simulates the human XFE progeroid syndrome. The model also accumulates DNA damage more rapidly, as well as aging approximately six times more quickly when compared with wild-type (WT) mice.

Published in Aging Cell, the study demonstrates that spontaneous DNA damage and impaired repair mechanisms can drive age-related retinal degeneration and vision loss, highlighting the role of oxidative stress in retinal health.

The UC Irvine-led study found that these Ercc1−/Δ mice exhibited severe visual impairments, including abnormal optokinetic responses and reduced electroretinogram amplitudes, as early as three months of age. The mice also displayed retinal thinning, photoreceptor loss, and vascular abnormalities similar to those observed in age-related macular degeneration (AMD). Elevated markers of DNA damage and cellular senescence were observed across retinal layers, implicating these processes as primary drivers of retinal aging.

The RPE of Ercc1−/Δ mice was particularly affected, displaying mitochondrial dysfunction and a metabolic shift toward glycolysis, a hallmark of aging cells. This disruption in energy production likely exacerbates photoreceptor degeneration, underscoring the critical symbiosis between the RPE and the neural retina.

The research emphasizes the potential of targeting DNA repair pathways and cellular senescence in developing novel treatments for AMD and other retinal diseases. By establishing the Ercc1−/Δ mouse as a model for retinal aging, the study offers a platform from which to further evaluate age-related retinal degeneration, as well as testing potential therapeutic interventions. The authors note that their work also reinforces existing literature’s claims that medications targeting both oxidative DNA damage and senescent cells could potentially be used for future AMD treatments.

About the Author(s)

The Ophthalmologist

More Articles by The Ophthalmologist

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: